On the other hand, in vitro activation of the immune checkpoint CD40/CD40L by endogenous expression of membrane-bound CD40L improves DC function and activates T-effector cells against several tumor types including CCA [96]. This evidence concerns the gene CD40 and cholangiocarcinoma.